Webcast recording now available.
Smart medicines to prevent counterfeiting and diversion of drug products.
Complex supply chains for pharmaceutical products make medicines increasingly vulnerable to counterfeiting and diversion and can lead to significant loss of revenue and reputational damage for the brand owner, as well as health risks and loss of trust for the consumer.
Going beyond the packaging with on-dose taggant solutions has been advised through the US Food and Drug Administration’s guidance on the use of physical-chemical identifiers in solid oral dosage forms.
Watch this webcast to learn how brand owners can implement smarter medicines with a more patient-centric approach while protecting their products from external threats and mitigating drug counterfeiting and product diversion.